DJIA 17,098.45 18.88 0.11%
NASDAQ 4,580.27 22.58 0.50%
S&P 500 2,003.37 6.63 0.33%
market minute promo

InterMune (NASDAQ: ITMN)

73.45 0.24 (0.33%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ITMN $73.45 0.33%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $73.29
Previous Close $73.21
Daily Range $73.25 - $73.52
52-Week Range $10.95 - $73.52
Market Cap $7.9B
P/E Ratio -28.16
Dividend (Yield) $0.00 (0.0%)
Volume 6,523,521
Average Daily Volume 5,029,344
Current FY EPS -$2.72

Sector

Healthcare

Industry

Drugs

InterMune (ITMN) Description

The Company is a biotech company focused on developing and commercializing innovative therapies in pulmonology and hepatology. Website: http://www.intermune.com/

News & Commentary

Up 35% on Buyout: InterMune inc Investor Key Takeaways

FDA's rejection of InterMune's Esbriet hurt investors, but Roche clearly thinks the drug will be approved.

What You Need to Know About the Roche-InterMune Deal

Markets Reverse Early Morning Losses; Still Lower On The Day

Benzinga's Top Initiations

Biotech Stock Roundup: Biotechs Surge on InterMune Acquisition Deal, Focus on More M&As - Analyst Bl

Biotech Stock Roundup: Biotechs Surge on InterMune Acquisition Deal, Focus on More M&As - Analyst Blog

Roche, InterMune a Strategic Play in Midst of Inversions

Should you buy ISIS? No, not that one

Today In SA PRO: Tuesday, August 26

Roche Furthers Immunotherapy Program with SP142 Launch - Analyst Blog

With An Iffy Non-Oncology Pipeline, Roche Pays Up For InterMune

Biotech ETFs Surge on InterMune-Roche Deal - ETF News And Commentary

See More ITMN News...

ITMN's Top Competitors

ITMN $73.45 (0.33%)
Current stock: ITMN
AMGN $139.38 (0.50%)
Current stock: AMGN
GILD $107.56 (0.05%)
Current stock: GILD
BIIB $343.04 (0.53%)
Current stock: BIIB